Research ArticleGastroenterology
Assessment of Ileocolonic Inflammation in Crohn’s Disease: Which Surrogate Marker Is Better—MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial
Yan Li, Jost Langhorst, Anna Katharina Koch, Aydin Demircioglu, Felix Nensa, Julian Kirchner, Karsten Beiderwellen, Onofrio Catalano, Michael Forsting, Ken Herrmann and Lale Umutlu
Journal of Nuclear Medicine June 2019, 60 (6) 851-857; DOI: https://doi.org/10.2967/jnumed.118.216937
Yan Li
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Jost Langhorst
2Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany
Anna Katharina Koch
2Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, University of Duisburg-Essen, Essen, Germany
Aydin Demircioglu
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Felix Nensa
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Julian Kirchner
3Department of Diagnostic and Interventional Radiology, University Hospital Dusseldorf, Düsseldorf, Germany
Karsten Beiderwellen
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
4Medizinisches Versorgungszentrum Prof. Dr. Uhlenbrock and Partner, Dortmund, Germany
Onofrio Catalano
5Abdominal Imaging and Martinos Center for Biomedical Imaging Research, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and
Michael Forsting
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Ken Herrmann
6Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Lale Umutlu
1Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 6
June 1, 2019
Assessment of Ileocolonic Inflammation in Crohn’s Disease: Which Surrogate Marker Is Better—MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial
Yan Li, Jost Langhorst, Anna Katharina Koch, Aydin Demircioglu, Felix Nensa, Julian Kirchner, Karsten Beiderwellen, Onofrio Catalano, Michael Forsting, Ken Herrmann, Lale Umutlu
Journal of Nuclear Medicine Jun 2019, 60 (6) 851-857; DOI: 10.2967/jnumed.118.216937
Assessment of Ileocolonic Inflammation in Crohn’s Disease: Which Surrogate Marker Is Better—MaRIA, Clermont, or PET/MR Index? Initial Results of a Feasibility Trial
Yan Li, Jost Langhorst, Anna Katharina Koch, Aydin Demircioglu, Felix Nensa, Julian Kirchner, Karsten Beiderwellen, Onofrio Catalano, Michael Forsting, Ken Herrmann, Lale Umutlu
Journal of Nuclear Medicine Jun 2019, 60 (6) 851-857; DOI: 10.2967/jnumed.118.216937
Jump to section
Related Articles
Cited By...
- No citing articles found.